318 related articles for article (PubMed ID: 10846053)
1. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
[TBL] [Abstract][Full Text] [Related]
2. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
[TBL] [Abstract][Full Text] [Related]
3. Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses.
Reinhart TA; Ghosh AK; Hoover EA; Mullins JI
J Virol; 1993 Sep; 67(9):5153-62. PubMed ID: 8394443
[TBL] [Abstract][Full Text] [Related]
4. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
Moser M; Burns CC; Boomer S; Overbaugh J
Virology; 1998 Mar; 242(2):366-77. PubMed ID: 9514965
[TBL] [Abstract][Full Text] [Related]
5. Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.
Cheng HH; Anderson MM; Hankenson FC; Johnston L; Kotwaliwale CV; Overbaugh J
J Virol; 2006 Feb; 80(4):1619-28. PubMed ID: 16439518
[TBL] [Abstract][Full Text] [Related]
6. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.
Lauring AS; Anderson MM; Overbaugh J
J Virol; 2001 Oct; 75(19):8888-98. PubMed ID: 11533152
[TBL] [Abstract][Full Text] [Related]
7. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
[TBL] [Abstract][Full Text] [Related]
8. Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein.
Poss ML; Quackenbush SL; Mullins JI; Hoover EA
J Virol; 1990 Sep; 64(9):4338-45. PubMed ID: 2166820
[TBL] [Abstract][Full Text] [Related]
9. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
Tailor CS; Kabat D
J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
[TBL] [Abstract][Full Text] [Related]
10. Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum.
Bolin LL; Chandhasin C; Lobelle-Rich PA; Albritton LM; Levy LS
Retrovirology; 2011 May; 8():35. PubMed ID: 21569491
[TBL] [Abstract][Full Text] [Related]
11. Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection.
Lauring AS; Cheng HH; Eiden MV; Overbaugh J
J Virol; 2002 Aug; 76(16):8069-78. PubMed ID: 12134012
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus.
Poss ML; Mullins JI; Hoover EA
J Virol; 1989 Jan; 63(1):189-95. PubMed ID: 2535725
[TBL] [Abstract][Full Text] [Related]
13. Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
Miyake A; Kawasaki J; Ngo H; Makundi I; Muto Y; Khan AH; Smith DJ; Nishigaki K
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996094
[TBL] [Abstract][Full Text] [Related]
14. Mutations within a putative cysteine loop of the transmembrane protein of an attenuated immunodeficiency-inducing feline leukemia virus variant inhibit envelope protein processing.
Burns CC; Poss ML; Thomas E; Overbaugh J
J Virol; 1995 Apr; 69(4):2126-32. PubMed ID: 7884859
[TBL] [Abstract][Full Text] [Related]
15. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
Farrell KB; Ting YT; Eiden MV
J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
[TBL] [Abstract][Full Text] [Related]
16. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.
Rigby MA; Rojko JL; Stewart MA; Kociba GJ; Cheney CM; Rezanka LJ; Mathes LE; Hartke JR; Jarrett O; Neil JC
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2839-47. PubMed ID: 1331290
[TBL] [Abstract][Full Text] [Related]
17. Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV.
Overbaugh J; Hoover EA; Mullins JI; Burns DP; Rudensey L; Quackenbush SL; Stallard V; Donahue PR
Virology; 1992 Jun; 188(2):558-69. PubMed ID: 1316674
[TBL] [Abstract][Full Text] [Related]
18. Delayed cytopathicity of a feline leukemia virus variant is due to four mutations in the transmembrane protein gene.
Thomas E; Overbaugh J
J Virol; 1993 Oct; 67(10):5724-32. PubMed ID: 8396654
[TBL] [Abstract][Full Text] [Related]
19. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.
Brojatsch J; Kristal BS; Viglianti GA; Khiroya R; Hoover EA; Mullins JI
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8457-61. PubMed ID: 1326757
[TBL] [Abstract][Full Text] [Related]
20. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
Chandhasin C; Coan PN; Levy LS
J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
